New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5.

MLA

Crea, Filippo. “New Therapeutic Targets to Reduce Inflammation-Associated Cardiovascular Risk: The CCL2-CCR2 Axis, LOX-1, and IRF5.” European Heart Journal, vol. 43, no. 19, May 2022, pp. 1777–81. EBSCOhost, https://doi.org/10.1093/eurheartj/ehac233.

APA

Crea, F. (2022). New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5. European Heart Journal, 43(19), 1777–1781. https://doi.org/10.1093/eurheartj/ehac233

Chicago

Crea, Filippo. 2022. “New Therapeutic Targets to Reduce Inflammation-Associated Cardiovascular Risk: The CCL2-CCR2 Axis, LOX-1, and IRF5.” European Heart Journal 43 (19): 1777–81. doi:10.1093/eurheartj/ehac233.